Granules India’s arm receives USFDA’s approval for Amphetamine Sulfate Tablets

06 Aug 2019 Evaluate

Granules India’s wholly owned foreign subsidiary -- Granules Pharmaceuticals, Inc. has received approval for the Abbreviated New Drug Application (ANDA) from US Food & Drug Administration (USFDA) for Amphetamine Sulfate Tablets USP 5 mg and 10 mg. It is bioequivalent to the reference listed drug product (RLD), Evekeo Tablets, 5 mg and 10 mg, of Arbor Pharmaceuticals, LLC.

Amphetamine Sulfate tablets is a central nervous system stimulant used to treat sleep disorder, increase attention, decrease impulsiveness and hyperactivity in patients with Attention Deficit Hyperactivity Disorder (ADHD).

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

579.90 14.95 (2.65%)
27-Jan-2026 11:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.60
Dr. Reddys Lab 1240.50
Cipla 1303.75
Zydus Lifesciences 890.00
Lupin 2139.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×